Optical transillumination spectroscopy provides an alternative to mammographic density as a biomarker of breast density and hence cancer risk, permitting frequent and early use thereby extending cancer risk assessment to younger women.
© 2005 Optical Society of America
(170.0170) Medical optics and biotechnology : Medical optics and biotechnology
(170.1610) Medical optics and biotechnology : Clinical applications
(170.3660) Medical optics and biotechnology : Light propagation in tissues
L. Lilge, K. M. Blackmore, J. A. Knight, and R. Jong, "Optical Transillumination Spectroscopy: A Biomarker of Breast Tissue Density and an Intermediate Indicator of Cancer Risk," in Novel Optical Instrumentation for Biomedical Applications II, C. Depeursinge, ed., Vol. 5864 of Proc. SPIE (Optical Society of America, 2005), paper TuH16.